GERRESHEIMER AG (GXI.DE) Fundamental Analysis & Valuation

FRA:GXI • DE000A0LD6E6

Current stock price

24.18 EUR
+0.2 (+0.83%)
Last:

This GXI.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. GXI.DE Profitability Analysis

1.1 Basic Checks

  • GXI had positive earnings in the past year.
  • GXI had a positive operating cash flow in the past year.
  • Each year in the past 5 years GXI has been profitable.
  • GXI had a positive operating cash flow in each of the past 5 years.
GXI.DE Yearly Net Income VS EBIT VS OCF VS FCFGXI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • GXI has a worse Return On Assets (0.50%) than 75.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 1.67%, GXI is doing worse than 75.00% of the companies in the same industry.
  • GXI has a Return On Invested Capital of 2.79%. This is in the lower half of the industry: GXI underperforms 75.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GXI is in line with the industry average of 7.18%.
Industry RankSector Rank
ROA 0.5%
ROE 1.67%
ROIC 2.79%
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
GXI.DE Yearly ROA, ROE, ROICGXI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • GXI has a worse Profit Margin (1.04%) than 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
  • GXI has a worse Operating Margin (5.99%) than 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of GXI has grown nicely.
  • GXI has a worse Gross Margin (26.89%) than 68.75% of its industry peers.
  • GXI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.99%
PM (TTM) 1.04%
GM 26.89%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
GXI.DE Yearly Profit, Operating, Gross MarginsGXI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

0

2. GXI.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GXI is destroying value.
  • Compared to 1 year ago, GXI has about the same amount of shares outstanding.
  • The number of shares outstanding for GXI has been increased compared to 5 years ago.
  • GXI has a worse debt/assets ratio than last year.
GXI.DE Yearly Shares OutstandingGXI.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GXI.DE Yearly Total Debt VS Total AssetsGXI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.94, we must say that GXI is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of GXI (0.94) is worse than 68.75% of its industry peers.
  • GXI has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
  • GXI has a Debt to Equity ratio of 1.22. This is in the lower half of the industry: GXI underperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 0.94
ROIC/WACC0.34
WACC8.29%
GXI.DE Yearly LT Debt VS Equity VS FCFGXI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that GXI may have some problems paying its short term obligations.
  • With a Current ratio value of 0.98, GXI is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • GXI has a Quick Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.52, GXI is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.52
GXI.DE Yearly Current Assets VS Current LiabilitesGXI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. GXI.DE Growth Analysis

3.1 Past

  • GXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.08%.
  • The Earnings Per Share has been decreasing by -8.23% on average over the past years.
  • GXI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.83%.
  • Measured over the past years, GXI shows a small growth in Revenue. The Revenue has been growing by 7.90% on average per year.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%

3.2 Future

  • GXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.35% yearly.
  • The Revenue is expected to grow by 6.88% on average over the next years.
EPS Next Y-53.76%
EPS Next 2Y-26.46%
EPS Next 3Y-9.08%
EPS Next 5Y3.35%
Revenue Next Year12.78%
Revenue Next 2Y7.56%
Revenue Next 3Y6.88%
Revenue Next 5Y6.88%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GXI.DE Yearly Revenue VS EstimatesGXI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
GXI.DE Yearly EPS VS EstimatesGXI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

5

4. GXI.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.55, the valuation of GXI can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of GXI indicates a rather cheap valuation: GXI is cheaper than 100.00% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.91. GXI is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 9.55, which indicates a very decent valuation of GXI.
  • Based on the Price/Forward Earnings ratio, GXI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • GXI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 6.55
Fwd PE 9.55
GXI.DE Price Earnings VS Forward Price EarningsGXI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 93.75% of the companies in the same industry are more expensive than GXI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.2
GXI.DE Per share dataGXI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as GXI's earnings are expected to decrease with -9.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.46%
EPS Next 3Y-9.08%

3

5. GXI.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.18%, GXI is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.57, GXI is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.82, GXI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
GXI.DE Yearly Dividends per shareGXI.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 10.12% of the earnings are spent on dividend by GXI. This is a low number and sustainable payout ratio.
  • The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP10.12%
EPS Next 2Y-26.46%
EPS Next 3Y-9.08%
GXI.DE Yearly Income VS Free CF VS DividendGXI.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
GXI.DE Dividend Payout.GXI.DE Dividend Payout, showing the Payout Ratio.GXI.DE Dividend Payout.PayoutRetained Earnings

GXI.DE Fundamentals: All Metrics, Ratios and Statistics

GERRESHEIMER AG

FRA:GXI (4/29/2026, 3:27:24 PM)

24.18

+0.2 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength12.16
Industry Growth92
Earnings (Last)04-16
Earnings (Next)07-14
Inst Owners93%
Inst Owner ChangeN/A
Ins Owners4.08%
Ins Owner ChangeN/A
Market Cap835.18M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts52.73
Price Target32.54 (34.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-6.02%
PT rev (3m)-15.45%
EPS NQ rev (1m)-94.61%
EPS NQ rev (3m)-374.67%
EPS NY rev (1m)0.79%
EPS NY rev (3m)-25.2%
Revenue NQ rev (1m)0.66%
Revenue NQ rev (3m)0.93%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE 6.55
Fwd PE 9.55
P/S 0.37
P/FCF N/A
P/OCF 3.29
P/B 0.6
P/tB N/A
EV/EBITDA 7.2
EPS(TTM)3.69
EY15.26%
EPS(NY)2.53
Fwd EY10.47%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY30.37%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.0494 (140.07%)
Profitability
Industry RankSector Rank
ROA 0.5%
ROE 1.67%
ROCE 3.76%
ROIC 2.79%
ROICexc 2.93%
ROICexgc 5.89%
OM 5.99%
PM (TTM) 1.04%
GM 26.89%
FCFM N/A
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA 4.4
Cap/Depr 134.54%
Cap/Sales 15.12%
Interest Coverage 1.65
Cash Conversion 65.42%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.52
Altman-Z 0.94
F-Score4
WACC8.29%
ROIC/WACC0.34
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-53.76%
EPS Next 2Y-26.46%
EPS Next 3Y-9.08%
EPS Next 5Y3.35%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year12.78%
Revenue Next 2Y7.56%
Revenue Next 3Y6.88%
Revenue Next 5Y6.88%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year81.16%
EBIT Next 3Y29.65%
EBIT Next 5Y19.49%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%

GERRESHEIMER AG / GXI.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.


What is the valuation status for GXI stock?

ChartMill assigns a valuation rating of 5 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for GERRESHEIMER AG?

GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for GXI stock?

The Price/Earnings (PE) ratio for GERRESHEIMER AG (GXI.DE) is 6.55 and the Price/Book (PB) ratio is 0.6.


How financially healthy is GERRESHEIMER AG?

The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.